NEW YORK (Reuters) – Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer and ...
The Food and Drug Administration on Friday approved a third vaccine for respiratory syncytial virus, clearing a shot from biotechnology company Moderna one year after granting a green light to ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Moderna has received its second drug approval from US regulators for an RSV vaccine in older adults, a step ...
Doctors believe the treatments - which are custom built for each patient - will herald a new era in cancer care, here MailOnline answers all your questions on the breakthrough jabs.
Moderna Inc. gained U.S. approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for COVID-19 shots. The ...
A researcher at the Moderna headquarters in Cambridge, Mass. (Adam Glanzman/Bloomberg News) Moderna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines, has hit ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...